ZIMMER BIOMET HOLDINGS, INC. Shakes Things Up (Again!): Stock Incentives & Legal Shield Upgrades in Latest 8-K Welcome back to your favorite ZIMMER BIOMET HOLDINGS,...
Zillow’s Shareholder Meeting: New Blood and the Same Old Auditors (June 2025) Welcome back to the Zillow chronicles, folks! Consider this your definitive guide to...
Xilio Therapeutics’ Warrant Tango: Cash Runway Extended, But at What Cost? 💸 Welcome back to the ongoing saga of Xilio Therapeutics, Inc. (XLO), where we...
Xeris Biopharma’s Analyst Day: $1 Billion in Revenue? Don’t Mind If I Do! Welcome back to your regularly scheduled programming on all things Xeris Biopharma...
Wynn Macau Tweaks Bond Conversion Price: Free Money? (Not Quite) Welcome back to the ongoing saga of WYNN RESORTS, LIMITED (WYNN)! Consider this your definitive...
Wabash National Braces for a Bumpy 2025: Tariff Troubles and Tight Wallets Ahead? Welcome back to the ongoing saga of Wabash National Corporation (WNC), where...
Wells Fargo Breaks Free: Asset Cap Lifted, Party Hats On! 🎉 Welcome back to the ongoing saga of Wells Fargo, folks! This is your definitive...
WBD Shareholders Speak: More Stock, More Power, Less Happy With Executive Pay (June 2025) Welcome back to the ongoing saga of Warner Bros. Discovery, Inc....
Ventas Just Cashed In: $500 Million Senior Notes Offering! 🤑 Welcome back to the ongoing saga of Ventas, Inc. (VTR), where we diligently decode their...
Victoria’s Secret: Q1 Sales Soar, But a Hacker’s in the Lingerie Drawer 👙 Welcome back to my ongoing deep dive into the fascinating world of...
